Ultrasonic Aspiration Versus CO2 Laser Ablation for the Treatment of Vulvar Intraepithelial Neoplasia

Completed · Not applicable

Conditions studied: Vulvar Intraepithelial Neoplasia (VIN)

In brief

The primary objective of this study is to evaluate the incidence of vulva dysplasia recurrence within 12 months of treatment with Carbon Dioxide (CO2) laser ablation or ultrasonic aspiration.

Key facts

Study ID

NCT02875561

Run by

University of Colorado, Denver

People needed

47

Starts

2017-03-26

Expected to finish

2023-04-20

Last updated by the study team

2023-11-18

Who can join

Age: 18 and older, up to 89. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women 18-89 years old
• Women diagnosed with high-grade VIN (diagnosed by pathology)
• Women referred for vulva sparing treatment for dysplasia
• Women available for follow-up of treatment for 12 months

You may not qualify if…

• Women who are pregnant
• Women with low-grade VIN dysplasia (diagnosed by pathology)
• Women with vaginal intraepithelial neoplasia(VAIN)
• Women requiring vulvectomy for treatment
• Women unable to provide informed consent

Where it is running

• University of Colorado Denver — Aurora, Colorado, United States
• University of Oklahoma — Norman, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.